G2V Optics Inc.’s Post

#fundingalert 💼Company: Cache DNA 💰Funding: Undisclosed ⚡Round: Seed 👥Investors: Climate Capital , Exor Ventures, Hawktail, LifeX Ventures, Pillar VC, and Trousdale Ventures, Illumina and Alec Nielsen. The life sciences industry is generating more sample data than labs can handle. Cache DNA is helping partners across the growing multi-omic landscape preserve molecular biospecimens, accelerate high-throughput applications, and achieve sustainable scale with its turnkey biobanking solutions. Cache is transforming sample management infrastructure by preserving precious biomolecules at room temperature, future-proofing samples in a more efficient footprint for discovery and validation for decades to come. Mark Bathe, Michael Becich, James Banal   Read more - https://lnkd.in/g8ijXcqb To share your startup story write us on - contact@startuprise.io #Cache #infrastructure #lifesciencesindustry #samplemanagement #biospecimens #funding #news #fundingnews #startup #startupnews #startupnews

Ventures ✨ w/ Alexis Borisy & Christoph Lengauer - Co-Founders @ Curie.Bio Join us on the BIOS Podcast for an enlightening conversation with Alexis Borisy and Christoph Lengauer, the pioneering co-founders of Curie Bio, as we explore the remarkable journeys that led them from the lab to the forefront of biotech entrepreneurship and venture capital. Dive deep into their stories, from Alexis's transition from chemistry scholar to biotech entrepreneur, to Christoph's balancing act between academia and industry, and discover the passion and vision behind Curie Bio. This episode not only sheds light on their individual paths but also delves into the innovative Curie model designed to revolutionize how therapeutics companies are launched. Learn about the strategic diligence process that separates signal from noise, the thoughtful approach to supporting portfolio companies, and the exciting future technologies that have Alexis and Christoph are excited to scale. Whether you're a founder, an investor, or simply fascinated by the intersection of technology and biology, this conversation offers unique insights into navigating the biotech landscape, building successful companies, and the exciting opportunities at the frontier of bio-innovation. Watch the full episode here: https://buff.ly/4071n3M #CurieBio #BiotechInnovation #VentureCapital #DrugDiscovery #TechBio #Entrepreneurship #LifeSciences #BiotechStartups #FutureOfHealthcare

Come watch Asclepii pitch!

Ventures ✨ w/ Alexis Borisy & Christoph Lengauer - Co-Founders @ Curie.Bio Join us on the BIOS Podcast for an enlightening conversation with Alexis Borisy and Christoph Lengauer, the pioneering co-founders of Curie Bio, as we explore the remarkable journeys that led them from the lab to the forefront of biotech entrepreneurship and venture capital. Dive deep into their stories, from Alexis's transition from chemistry scholar to biotech entrepreneur, to Christoph's balancing act between academia and industry, and discover the passion and vision behind Curie Bio. This episode not only sheds light on their individual paths but also delves into the innovative Curie model designed to revolutionize how therapeutics companies are launched. Learn about the strategic diligence process that separates signal from noise, the thoughtful approach to supporting portfolio companies, and the exciting future technologies that have Alexis and Christoph are excited to scale. Whether you're a founder, an investor, or simply fascinated by the intersection of technology and biology, this conversation offers unique insights into navigating the biotech landscape, building successful companies, and the exciting opportunities at the frontier of bio-innovation. Watch the full episode here: https://buff.ly/4071n3M #CurieBio #BiotechInnovation #VentureCapital #DrugDiscovery #TechBio #Entrepreneurship #LifeSciences #BiotechStartups #FutureOfHealthcare

SFBN Feed: Two biotech veterans armed with $70M seek next big idea in life sciences https://lnkd.in/gH3ssnc7 An investor group with big wallets is making a $70 million bet on life science startups. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks #BayArea #SanFrancisco #Biotech #Lifescience #News

Ventures ✨ w/ Alexis Borisy & Christoph Lengauer - Co-Founders @ Curie.Bio Join us on the BIOS Podcast for an enlightening conversation with Alexis Borisy and Christoph Lengauer, the pioneering co-founders of Curie Bio, as we explore the remarkable journeys that led them from the lab to the forefront of biotech entrepreneurship and venture capital. Dive deep into their stories, from Alexis's transition from chemistry scholar to biotech entrepreneur, to Christoph's balancing act between academia and industry, and discover the passion and vision behind Curie Bio. This episode not only sheds light on their individual paths but also delves into the innovative Curie model designed to revolutionize how therapeutics companies are launched. Learn about the strategic diligence process that separates signal from noise, the thoughtful approach to supporting portfolio companies, and the exciting future technologies that have Alexis and Christoph are excited to scale. Whether you're a founder, an investor, or simply fascinated by the intersection of technology and biology, this conversation offers unique insights into navigating the biotech landscape, building successful companies, and the exciting opportunities at the frontier of bio-innovation. Watch the full episode here: https://buff.ly/4071n3M #CurieBio #BiotechInnovation #VentureCapital #DrugDiscovery #TechBio #Entrepreneurship #LifeSciences #BiotechStartups #FutureOfHealthcare

Want to be “in the room where it happens”? Then join us October 16 in Manchester NH for our Investment Summit. Download the agenda on the event page to learn more about the 15 companies vying for $100K investment prize as well as engaging panels and spotlight companies! As the tagline says - “Come curious, leave inspired”

#fundingalert 💼Company: Vivalyx  💰Funding: €5.4Million ⚡Round: Seed 👥Investors: Consortium, Brightlands Venture Partners, TVF | TechVision Fonds, Arve Capital, Thomas Ebeling, Andrej Henkler, Springboard Health Angels. Vivalyx GmbH, a biotech company was founded in 2022 in Aachen by Andreas Schumacher, Benedict Doorschodt, René H. Tolba, Christian Bleilevens, Malte Brettel, and Marius Rosenberg. The funding enables it to finance the clinical study required for regulatory approval. This crucial step paves the way for the launch of the innovative organ preservation solution, which has the potential to extend the lifespan of donor organs and enhance their vitality. Luc Starmans, Bernhard Kugel, Andrej Henkler Read more - https://lnkd.in/ggpZz5wE To share your startup story write us on - contact@startuprise.co.uk #Vivalyx #biotech #finance #vitality #funding #fundingnews #startupnews #startuprise

My 6 outcomes for startups after mentoring at MassChallenge My first MassChallenge cohort as a mentor is complete. Mentoring a diverse group of startups during the MassChallenge cohort has been an incredibly rewarding journey. I've had the privilege to witness firsthand the challenges, breakthroughs, and determination of early-stage founders. This experience not only enriched my perspective but also highlighted several key lessons that I believe are crucial for startup success. My personal insights for early-stage startupers I want to share: 1. Develop a market-fit mindset. The best ideas are those that resonate with real market needs, not just theoretical possibilities. Start by listening to your potential customers, validating their pain points, and iterating quickly based on feedback. A market-fit mindset keeps you flexible and focused on delivering value rather than falling in love with a preconceived notion. 2. Your idea is not a product. An idea is just the starting point; the real work begins when you start turning it into something tangible. A product requires planning, prototyping, user testing, and execution to bring it to life. Remember, customers don't buy ideas—they buy solutions that solve their problems. 3. Building the right team. A great idea without a great team is likely to fail. Surround yourself with people who complement your skills, share your vision, and bring diverse perspectives to the table. A strong team with shared values and clear roles is the foundation of any successful startup. 4. Customer acquisition as a process. Acquiring customers isn't a one-time task; it's a systematic, evolving process. You need to identify your audience, test different acquisition channels, and refine your approach based on performance metrics. Treating customer acquisition as a core business process ensures sustainable growth over time. 5. Set your metrics and deadlines. Metrics are the pulse of your startup; they help you measure progress and make informed decisions. Deadlines create urgency and keep your team focused. By defining clear goals and timelines, you create a framework for accountability and maintain momentum toward achieving milestones. 6. Investors are not investing in your idea. Investors care about execution, market potential, and the team's ability to deliver—not just the idea itself. A compelling pitch should demonstrate traction, a clear go-to-market strategy, and why your team is the one to bring the idea to life. In other words, they invest in the vision and the execution capability behind the idea. Each insight stems from my experience and observations, and I hope they provide value to founders navigating the challenging yet rewarding world of startups!

Excited to be speaking tomorrow at Loci Labs, a one-of-a-kind biotech coworking space in Buenos Aires! Loci Labs isn't just about offices and an auditorium; it boasts 400m² of fully-equipped laboratories and 140m² of clean rooms. Everything is ready for cell and molecular biology, media preparation, sterilization, and even pathogen research with BSL-2 safety standards. By my estimate, there’s over $1M worth of equipment in there! As you can imagine, running such a facility on a coworking model wouldn’t be sustainable. That’s why Loci Labs also operates as an early-stage incubator and investment fund. Their unique approach allows them to witness the daily progress of every team inside, offering investment opportunities to the most promising projects. As a venture partner at Sky High VC fund, I’m excited to support Loci Labs and will be delivering a lecture on “Why Invest in Biotechnology?” tomorrow, September 24th at 14:00. If you’re in Buenos Aires, feel free to join us — admission is free! #Biotech #VentureCapital #Startups #Innovation #Investment #BuenosAires #LociLabs #SkyHighVC